Current stage of preclinical and clinical development of guggulsterone in cancers : Challenges and promises
© 2023 International Federation of Cell Biology..
Throughout human history, the utilization of medicinal herbs has been recognized as a crucial defense against various ailments, including cancer. Natural products with potential anticancer properties, capable of inducing apoptosis in cancer cells, have garnered substantial attention. One such agent under investigation is guggulsterone (GS), a phytosterol derived from the gum resin of the Commiphora mukul tree. This review aims to provide a comprehensive summary of recent studies elucidating the anticancer molecular mechanisms and molecular targets of GS, guiding future research and potential applications as an adjuvant drug in cancer therapy. Recent in vivo and in vitro studies have explored the biological activities of the active ingredients in Commiphora mukul. Specifically, GS emerges as a potential cancer chemopreventive and therapeutic agent. The investigations delve into the impact of GS on constitutively activated survival pathways, including Janus kinase/signal transducer and activator of transcription (JAK/STAT), nuclear factor-kappa B (NF-kB), and PI3-kinase/AKT signaling pathways. These pathways regulate antiapoptotic and proinflammatory genes, exerting control over growth and inflammatory responses. The findings highlight the potential of GS in disrupting survival pathways crucial for cancer cell viability. The inhibition of JAK/STAT, NF-kB, and PI3-kinase/AKT signaling pathways positions GS as a promising candidate for cancer therapy. The review synthesizes evidence from diverse studies, underscoring the multifaceted biological activities of GS in cancer prevention and treatment. To advance our understanding, future clinical and translational studies are imperative to determine effective doses in humans. Additionally, there is a need for the development of new pharmaceutical forms of GS to optimize therapeutic effects. This comprehensive review provides a foundation for ongoing research, offering insights into the potential of GS as a valuable addition to the armamentarium against cancer.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Cell biology international - 48(2024), 2 vom: 26. Jan., Seite 128-142 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ijaz, Shumaila [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 18.01.2024 Date Revised 18.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/cbin.12112 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366393634 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366393634 | ||
| 003 | DE-627 | ||
| 005 | 20240118232048.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cbin.12112 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1263.xml |
| 035 | |a (DE-627)NLM366393634 | ||
| 035 | |a (NLM)38148708 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ijaz, Shumaila |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Current stage of preclinical and clinical development of guggulsterone in cancers |b Challenges and promises |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.01.2024 | ||
| 500 | |a Date Revised 18.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 International Federation of Cell Biology. | ||
| 520 | |a Throughout human history, the utilization of medicinal herbs has been recognized as a crucial defense against various ailments, including cancer. Natural products with potential anticancer properties, capable of inducing apoptosis in cancer cells, have garnered substantial attention. One such agent under investigation is guggulsterone (GS), a phytosterol derived from the gum resin of the Commiphora mukul tree. This review aims to provide a comprehensive summary of recent studies elucidating the anticancer molecular mechanisms and molecular targets of GS, guiding future research and potential applications as an adjuvant drug in cancer therapy. Recent in vivo and in vitro studies have explored the biological activities of the active ingredients in Commiphora mukul. Specifically, GS emerges as a potential cancer chemopreventive and therapeutic agent. The investigations delve into the impact of GS on constitutively activated survival pathways, including Janus kinase/signal transducer and activator of transcription (JAK/STAT), nuclear factor-kappa B (NF-kB), and PI3-kinase/AKT signaling pathways. These pathways regulate antiapoptotic and proinflammatory genes, exerting control over growth and inflammatory responses. The findings highlight the potential of GS in disrupting survival pathways crucial for cancer cell viability. The inhibition of JAK/STAT, NF-kB, and PI3-kinase/AKT signaling pathways positions GS as a promising candidate for cancer therapy. The review synthesizes evidence from diverse studies, underscoring the multifaceted biological activities of GS in cancer prevention and treatment. To advance our understanding, future clinical and translational studies are imperative to determine effective doses in humans. Additionally, there is a need for the development of new pharmaceutical forms of GS to optimize therapeutic effects. This comprehensive review provides a foundation for ongoing research, offering insights into the potential of GS as a valuable addition to the armamentarium against cancer | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Commiphora mukul | |
| 650 | 4 | |a antitumor | |
| 650 | 4 | |a apoptosis | |
| 650 | 4 | |a guggulsterone | |
| 650 | 4 | |a pharmacology | |
| 650 | 7 | |a NF-kappa B |2 NLM | |
| 650 | 7 | |a pregna-4,17-diene-3,16-dione |2 NLM | |
| 650 | 7 | |a A4PW148END |2 NLM | |
| 650 | 7 | |a Proto-Oncogene Proteins c-akt |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 650 | 7 | |a Phosphatidylinositol 3-Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.1.- |2 NLM | |
| 650 | 7 | |a Pregnenediones |2 NLM | |
| 700 | 1 | |a Iqbal, Javed |e verfasserin |4 aut | |
| 700 | 1 | |a Abbasi, Banzeer Ahsan |e verfasserin |4 aut | |
| 700 | 1 | |a Tufail, Aasma |e verfasserin |4 aut | |
| 700 | 1 | |a Yaseen, Tabassum |e verfasserin |4 aut | |
| 700 | 1 | |a Uddin, Siraj |e verfasserin |4 aut | |
| 700 | 1 | |a Usman, Kiran |e verfasserin |4 aut | |
| 700 | 1 | |a Ullah, Rafi |e verfasserin |4 aut | |
| 700 | 1 | |a Bibi, Haseena |e verfasserin |4 aut | |
| 700 | 1 | |a Inam, Palwasha |e verfasserin |4 aut | |
| 700 | 1 | |a Sagindykova, Elvira |e verfasserin |4 aut | |
| 700 | 1 | |a Gürer, Eda Sönmez |e verfasserin |4 aut | |
| 700 | 1 | |a Habtemariam, Solomon |e verfasserin |4 aut | |
| 700 | 1 | |a Calina, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Sharifi-Rad, Javad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell biology international |d 1995 |g 48(2024), 2 vom: 26. Jan., Seite 128-142 |w (DE-627)NLM074832263 |x 1095-8355 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2024 |g number:2 |g day:26 |g month:01 |g pages:128-142 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/cbin.12112 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2024 |e 2 |b 26 |c 01 |h 128-142 | ||